Bewarder, Moritz
Held, Gerhard
Thurner, Lorenz
Stilgenbauer, Stephan
Smola, Sigrun
Preuss, Klaus-Dieter
Carbon, Gabi
Bette, Birgit
Christofyllakis, Konstantinos
Bittenbring, Joerg Thomas
Felbel, Arne
Hasse, Alexander
Murawski, Niels
Kaddu-Mulindwa, Dominic
Neumann, Frank
Article History
Received: 1 September 2019
Accepted: 2 April 2020
First Online: 16 April 2020
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: The study was conducted in accordance with the Helsinki Declaration and approved by the local ethics committee (Ärztekammer des Saarlandes, ID 110/19). HLA-typed, healthy donors of blood and skin biopsies gave written informed consent prior to study inclusion.
: The melanoma cell lines Me 260 and Me 275 were provided by the Ludwig Institute for Cancer Research, Lausanne, Switzerland. The melanoma cell line SK-mel-23 was provided by the Memorial Sloan Kettering Cancer Center, New York, USA. Cell lines A-431 (ATCC® CRL-1555) and MRC-5 (ATCC® CCL-171™) were bought from ATCC, Manassas, Virginia, USA.